Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Drivers
4.1.1 Growing use of magnesium stearate as fillers & binders and lubricants in the pharmaceutical industry
4.1.2 Increasing use in the production of dietary supplements
4.2 Restraint
4.2.1 Health risk associated with magnesium stearate
4.2.2 Probable contamination during manufacturing
4.3 Industry Value-Chain Analysis
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Degree of Competition
4.5 Policies & Regulations


5 MARKET SEGMENTATION
5.1 End-User Industry
5.1.1 Pharmaceutical
5.1.2 Food & Beverage
5.1.3 Personal Care
5.1.4 Plastics
5.1.5 Other End-User Industries (Paints& Coatings, etc.)
5.2 Geography
5.2.1 Asia-Pacific
5.2.1.1 China
5.2.1.2 India
5.2.1.3 Japan
5.2.1.4 South Korea
5.2.1.5 Rest of Asia-Pacific
5.2.2 North America
5.2.2.1 United States
5.2.2.2 Canada
5.2.2.3 Mexico
5.2.3 Europe
5.2.3.1 Germany
5.2.3.2 United Kingdom
5.2.3.3 Italy
5.2.3.4 France
5.2.3.5 Rest of Europe
5.2.4 Rest of the World


6 COMPETITIVE LANDSCAPE
6.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
6.2 Market Share Analysis**
6.3 Strategies Adopted by Leading Players
6.4 Company Profiles
6.4.1 Baerlocher GmbH
6.4.2 FACI SPA
6.4.3 James M. Brown Ltd.
6.4.4 NB Entrepreneurs
6.4.5 Nimbasia
6.4.6 Norac Additives, LLC
6.4.7 PT Halim Sakti Pratama
6.4.8 Valtris Specialty Chemicals


7 MARKET OPPORTUNITIES AND FUTURE TRENDS